[APLS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
08-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 10.78%
YoY- -44.12%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 16,322 14,381 60,290 5,650 623 0 250,000 -83.86%
PBT -155,491 -137,727 -147,581 -195,571 -219,191 -183,659 80,110 -
Tax 486 1,208 352 2,165 3,706 5,719 2 3833.44%
NP -155,977 -138,935 -147,933 -195,571 -219,191 -183,659 78,265 -
Tax Rate - - - - - - -0.00% -
Total Cost 172,299 153,316 208,223 201,221 219,814 183,659 171,735 0.21%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -955.62 -966.10 -245.37 -3,461.43 -35,183.15 0.00 31.31 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -1.46 -1.42 -1.73 -2.28 -2.72 -2.32 0.99 -
EPS Diluted -1.46 -1.42 -1.73 -2.28 -2.72 -2.32 0.99 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.